Why the study?
Does rapidly injected intravenous diazoxide reduce mean arterial pressure in patients with severe hypertension?
Population
33 patients with severe hypertension
Design
Case_series
Follow-up
16 hours (average duration of effect)
Authors
Loading...
May support IV diazoxide for acute MAP reduction in severe hypertension; hypothesis-generating and requires controlled validation.
Does rapidly injected intravenous diazoxide reduce mean arterial pressure in patients with severe hypertension?
Intravenous diazoxide provides rapid and profound blood pressure reduction without impairing renal function in patients with severe hypertension.
Hamby et al. (1968) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: